Mundipharma GmbH
🇩🇪Germany
Clinical Trials
4
Active:2
Completed:2
Trial Phases
0 Phases
Drug Approvals
12
NMPA:10
EMA:2
Drug Approvals
Buprenorphine Transdermal Patches
- Product Name
- 丁丙诺啡透皮贴剂
- Approval Number
- 国药准字HJ20181096
- Approval Date
- Nov 16, 2022
NMPA
Buprenorphine Transdermal Patches
- Product Name
- 丁丙诺啡透皮贴剂
- Approval Number
- 国药准字HJ20181046
- Approval Date
- Nov 16, 2022
NMPA
Buprenorphine Transdermal Patches
- Product Name
- 丁丙诺啡透皮贴剂
- Approval Number
- 国药准字HJ20181047
- Approval Date
- Nov 16, 2022
NMPA
Buprenorphine Transdermal Patches
- Product Name
- 丁丙诺啡透皮贴剂
- Approval Number
- 国药准字HJ20181111
- Approval Date
- Nov 16, 2022
NMPA
Buprenorphine Transdermal Patches
- Product Name
- 丁丙诺啡透皮贴剂
- Approval Number
- 国药准字HJ20181113
- Approval Date
- Nov 16, 2022
NMPA
Buprenorphine Transdermal Patches
- Product Name
- 丁丙诺啡透皮贴剂
- Approval Number
- 国药准字HJ20181112
- Approval Date
- Nov 16, 2022
NMPA
Tramadol Hydrochloride Sustained-release Tablets
- Product Name
- 盐酸曲马多缓释片
- Approval Number
- 国药准字HJ20120382
- Approval Date
- Apr 1, 2021
NMPA
Tramadol Hydrochloride Sustained-release Tablets
- Product Name
- 盐酸曲马多缓释片
- Approval Number
- 国药准字HJ20120383
- Approval Date
- Apr 1, 2021
NMPA
Buprenorphine Transdermal Patches
- Product Name
- 丁丙诺啡透皮贴剂
- Approval Number
- 国药准字J20130124
- Approval Date
- Dec 25, 2019
NMPA
Buprenorphine Transdermal Patches
- Product Name
- 丁丙诺啡透皮贴剂
- Approval Number
- 国药准字J20130126
- Approval Date
- Dec 25, 2019
NMPA
Clinical Trials
No trials found
News
No news found